Recurrent Aphthous Stomatitis: Treatment and Management
Keywords:
oral, recurrent, autoimmune, treatment, herpetiform, aphthosis, Behçet disease, aphthaeAbstract
Background: Recurrent aphthous stomatitis consists of the presence of abrasions or ulcerations located on mucosae (oral or genital).
Objectives: The aim of this article is to review the current literature providing the main causes related to recurrent aphthous stomatitis and insights into treatment and management of this clinical condition
Methods: Articles matching terms that correlated with “recurrent aphthous stomatitis” were searched on PubMed, EMBASE, and Cochrane Library and selected according to their pertinence.
Results: Several forms of aphthous stomatitis have been described, based on the extent (minor, major), morphology (herpetiform), and associations to other signs (Behçet syndrome or more complex inflammatory syndromes). Topical as well as systemic treatments have been described to obtain a faster remission of the aphthosis or to reduce associated symptoms such as pain.
Conclusions: Recurrent aphthous stomatitis can have a mild-to-severe clinical appearance, being mainly localized on the oral mucosa or at the level of the genital area. Different strategies have been described so far for its management and treatment.
References
Giannetti L, Murri Dello Diago A, Lo Muzio L. Recurrent aphtous stomatitis. Minerva Stomatol. 2018;67(3):125–128. DOI: 10.23736/S0026-4970.18.04137-7. PMID: 29332375.
Edgar NR, Saleh D, Miller RA. Recurrent aphthous stomatitis: a review. J Clin Aesthetic Dermatol. 2017;10(3):26–36.
Giannetti L, Generali L, Bertoldi C. Oral pemphigus. G Ital Dermatol Venereol. 2018;153(3):383–388. DOI: 10.23736/S0392-0488.18.05887-X. PMID: 29512980.
Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019 ;394(10201):882–894. DOI: 10.1016/S0140-6736(19)31778-7.
Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308(8):539–551. DOI: 10.1007/s00403-016-1667-2. PMID: 27349424.
Giannetti L, Dello Diago AM, Spinas E. Oral lichen planus. J Biol Regul Homeost Agents. 2018;32(2):391–395. PMID: 29685024.
Adamski Z, Burchardt D, Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Wyganowska-Świątkowska M. Diagnosis of Papillon-Lefèvre syndrome: review of the literature and a case report. Postepy Dermatol Alergol. 2020;37(5):671–676. DOI: 10.5114/ada.2020.100480. PMID: 33240004.
Ferreli C, Giannetti L, Robustelli Test E, Atzori L, Rongioletti F. Linear white lesion in the oral mucosa. JAAD Case Rep. 2019;5(8):694–696. DOI: 10.1016/j.jdcr.2019.05.009. PMID: 31440559.
Castori M, Madonna S, Giannetti L, et al. Novel CTSC mutations in a patient with Papillon-Lefèvre syndrome with recurrent pyoderma and minimal oral and palmoplantar involvement. Br J Dermatol. 2009;160(4):881–883. DOI: 10.1111/j.1365-2133.2008.08878.x. PMID: 18945301.
Giannetti L, Apponi R, Dello Diago AM, Jafferany M, Goldust M, Sadoughifar R. Papillon-Lefèvre syndrome: Oral aspects and treatment. Dermatol Ther. 2020;33(3):e13336. DOI: 10.1111/dth.13336. PMID: 32222110.
Altenburg A, Zouboulis CC. Current concepts in the treatment of recurrent aphthous stomatitis. Skin Ther Lett. 2008;13(7):1–4. PMID: 18839042.
Yasui K, Kurata T, Yashiro M, Tsuge M, Ohtsuki S, Morishima T. The effect of ascorbate on minor recurrent aphthous stomatitis. Acta Paediatr. 1992. 2010;99(3):442–445. DOI: 10.1111/j.1651-2227.2009.01628.x. PMID: 20003102.
Montgomery-Cranny JA, Wallace A, Rogers HJ, Hughes SC, Hegarty AM, Zaitoun H. Management of recurrent aphthous stomatitis in children. Dent Update. 2015;42(6):564–566, 569–572. DOI: 10.12968/denu.2015.42.6.564. PMID: 26506812.
Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol. 2017;35(5):421–434. DOI: 10.1016/j.clindermatol.2017.06.004. PMID: 28916023.
Giannetti L, Murri Dello Diago A, Lo Muzio L. Behçet’s disease: minireview with emphasis on oral aspects. Minerva Stomatol. 2018;67(6):246–249. DOI: 10.23736/S0026-4970.18.04135-3.
Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behçet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011;41(1):61–70. DOI: 10.1016/j.semarthrit.2010.09.002. PMID: 21168186.
Mandel VD, Farnetani F, Vaschieri C, et al. Pemphigus with features of both vulgaris and foliaceus variants localized to the nose. J Dermatol. 2016;43(8):940–943. DOI: 10.1111/1346-8138.13314. PMID: 26945696.
Celentano A, Tovaru S, Yap T, Adamo D, Aria M, Mignogna MD. Oral erythema multiforme: trends and clinical findings of a large retrospective European case series. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(6):707–716. DOI: 10.1016/j.oooo.2015.08.010. PMID: 26455287.
Ponti G, Tomasi A, Manfredini M, Pellacani G. Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies. Gene. 2016;582(1):23–32. DOI: 10.1016/j.gene.2016.01.053. PMID: 26850131.
Ponti G, Meschieri A, Pollio A, et al. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy. J Oral Pathol Med. 2015;44(7):552–557. DOI: 10.1111/jop.12256. PMID: 25213213.
Lê Thi Huong D, Wechsler B, Piette JC, et al. Aortic insufficiency and recurrent valve prosthesis dehiscence in MAGIC syndrome. J Rheumatol. 1993;20(2):397–398.
Delke I, Veridiano NP, Tancer ML, Gomez L, Diamond I. Sweet syndrome with involvement of the female genital tract. Obstet Gynecol. 1981;58(3):394–396.
Driban NE, Alvarez MA. Oral manifestations of Sweet’s syndrome. Dermatologica. 1984;169(2):102–103. DOI: 10.1159/000249579.
Mizoguchi M, Matsuki K, Mochizuki M, et al. Human leukocyte antigen in Sweet’s syndrome and its relationship to Behçet’s disease. Arch Dermatol. 1988;124(7):1069–1073. DOI: 10.1001/archderm.1988.01670070057019. PMID: 3389850.
von den Driesch P, Gomez RS, Kiesewetter F, Hornstein OP. Sweet’s syndrome: clinical spectrum and associated conditions. Cutis. 1989;44(3):193–200.
Bruyn GA, Missier ET, Toonstra J, Bijlsma JW. Sweet’s syndrome. Neth J Med. 1990;36(1–2):62–68.
von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31(4):535–56. DOI: 10.1016/S0190-9622(94)70215-2.
Femiano F, Gombos F, Scully C. Sweet’s syndrome: recurrent oral ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Mar;95(3):324–327. DOI: 10.1067/moe.2003.4. PMID: 12627104.
Lange RD, Jones JB. Cyclic neutropenia. Review of clinical manifestations and management. Am J Pediatr Hematol Oncol. 1981;3(4):363–367.
Scully C, MacFadyen E, Campbell A. Oral manifestations in cyclic neutropenia. Br J Oral Surg. 1982;20(2):96–101. DOI: 10.1016/0007-117X(82)90015-4.
Sucker C, Djawari J. [Recurrent episodes of ulcerative gingivostomatitis associated with cyclic neutropenia]. Hautarzt.1999;50(7):503–506. DOI: /10.1007/s001050050042.
Lubitz PA, Dower N, Krol AL. Cyclic neutropenia: an unusual disorder of granulopoiesis effectively treated with recombinant granulocyte colony-stimulating factor. Pediatr Dermatol. 2001;18(5):426–432. DOI: 10.1046/j.1525-1470.2001.01974.x. PMID: 11737691.
Marshall GS, Edwards KM, Butler J, Lawton AR. Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr. 1987;110(1):43–6.
Feder HM. Periodic fever, aphthous stomatitis, pharyngitis, adenitis: a clinical review of a new syndrome. Curr Opin Pediatr. 2000;12(3):253–256. DOI: 10.1097/00008480-200006000-00014. PMID: 10836162.
Kawashima H, Nishimata S, Shimizu T, Kashiwagi Y, Takekuma K, Hoshika A. Highly suspected case of FAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) syndrome. Pediatr Int. 2001;43(1):103–106. DOI: 10.1046/j.1442-200x.2001.01331.x. PMID: 11208014.
Grattan CE, Scully C. Oral ulceration: a diagnostic problem. Br Med J (Clin Res Ed). 1986;292(6528):1093–1094. DOI: 10.1136/bmj.292.6528.1093. PMID: 3084011.
Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature. Oral Surg Oral Med Oral Pathol. 1994;77(6):555–571. DOI: 10.1016/0030-4220(94)90312-3.
Porter SR, Scully C, Luker J. Complications of dental surgery in persons with HIV disease. Oral Surg Oral Med Oral Pathol. 1993;75(2):165–167. DOI: 10.1016/0030-4220(93)90087-K.
Scully C, Porter SR. Oral mucosal disease: a decade of new entities, aetiologies and associations. Int Dent J. 1994;44(1):33–43. PMID: 8021031.
MacPhail LA, Greenspan JS. Oral ulceration in HIV infection: investigation and pathogenesis. Oral Dis. 1997;3 Suppl 1:S190-193. DOI: 10.1111/j.1601-0825.1997.tb00358.x. PMID: 9456687.
Zakrzewska JM, Robinson P, Williams IG. Severe oral ulceration in patients with HIV infection: a case series. Oral Dis. 1997;3 Suppl 1:S194-196. DOI: 10.1111/j.1601-0825.1997.tb00359.x. PMID: 9456688.
Li L, Gu H, Zhang G. Association between recurrent aphthous stomatitis and Helicobacter pylori infection: a meta-analysis. Clin Oral Investig. 2014;18(6):1553–1560. DOI: 10.1007/s00784-014-1230-5. PMID: 24682540.
Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12(3):254–270. DOI: 10.1111/j.1601-0825.2006.01202.x. PMID: 16700734.
Fitzpatrick SG, Cohen DM, Clark AN. Ulcerated Lesions of the oral mucosa: clinical and histologic review. Head Neck Pathol. 2019;13(1):91–102. DOI: 10.1007/s12105-018-0981-8. PMID: 30701449.
Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K, Sharma AM. The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India. Eur J Dent. 2015;9(1):47–52.
Giannetti L, Murri Dello Diago A, Lo Muzio L. Recurrent aphtous stomatitis. Minerva Stomatol. 2018;67(3):125–8. DOI: 10.23736/S0026-4970.18.04137-7. PMID: 29332375.
Dalessandri D, Zotti F, Laffranchi L, Migliorati M, Isola G, Bonetti S, et al. Treatment of recurrent aphthous stomatitis (RAS; aphthae; canker sores) with a barrier forming mouth rinse or topical gel formulation containing hyaluronic acid: a retrospective clinical study. BMC Oral Health. 2019;19(1):153. DOI: 10.1186/s12903-019-0850-1. PMID: 31311529.
Carl W, Havens J. The cancer patient with severe mucositis. Curr Rev Pain. 2000;4(3):197–202. DOI: 10.1007/s11916-000-0079-2.
Sharquie KE, Helmi RMA, Noiami AA, Al-Hayani RK, Kadhom MAA. The therapeutic role of isotretinoin in the management of Behçet’s disease: a single-blinded, controlled therapeutic study. J Drugs Dermatol.2013;12(4):e68-73.
Elad S, Epstein JB, von Bültzingslöwen I, Drucker S, Tzach R, Yarom N. Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents. Expert Opin Emerg Drugs. 2011;16(1):183–202. DOI: 10.1517/14728214.2011.528390. PMID: 21244328.
Mumcu G, Ergun T, Elbir Y, et al. Clinical and immunological effects of azithromycin in Behçet’s disease. J Oral Pathol Med.2005;34(1):13–16. DOI: 10.1111/j.1600-0714.2004.00265.x. PMID: 15610401.
Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol. 2002;138(4):467–471. DOI: 10.1001/archderm.138.4.467. PMID: 11939808.
Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL. Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018;178(2):350–6. DOI: 10.1111/bjd.15896. PMID: 28832953.
Harte MC, Saunsbury TA, Hodgson TA. Thalidomide use in the management of oromucosal disease: A 10-year review of safety and efficacy in 12 patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(4):398–401. DOI: 10.1016/j.oooo.2020.06.009. PMID: 32622799.
Radulescu M. The pharmacologic management of common lesions of the oral cavity. Dent Clin North Am. 2016;60(2):407–420. DOI: 10.1016/j.cden.2015.12.003. PMID: 27040292.
Akerzoul N, Chbicheb S. Low laser therapy as an effective treatment of recurrent aphtous ulcers: a clinical case reporting two locations. Pan Afr Med J. 2018;30:205. PMID: 30574224.
Published
Issue
Section
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
